max)和肺動(dòng)脈壓(PAPs)及ET-1水平,同時(shí)比較兩組凝血功能指標(biāo)。結(jié)果 對(duì)照組總有效率為86.9%,觀察組為98.4%,觀察組顯著高于對(duì)照組(P<0.05)。治療后兩組的Vmax值、PAPs值與血漿ET-1含量均顯著低于治療前(P<0.05),且觀察組顯著低于對(duì)照組(P<0.05)。治療后兩組的凝血酶原時(shí)間(PT)、活化部分凝血活酶時(shí)間(APTT)與凝血酶時(shí)間(TT)值都顯著高于治療前(P<0.05),且治療后觀察組顯著高于對(duì)照組(P<0.05)。結(jié)論 疏血通注射液聯(lián)合納洛酮治療慢性肺心病急性加重期能抑制血漿ET-1的表達(dá),改善肺動(dòng)脈壓力,具有抗凝的作用,從而有利于提高治療療效。;Objective To investigate the effect of Shuxuetong Injection on plasma endothelin (ET-1) in acute exacerbation of chronic pulmonary heart disease.Methods Used a random draw and retrospective study, From February 2010 to December 2016, 122 cases of acute exacerbation of chronic pulmonary heart disease in our hospital were selected and were ivided into observation group and control group with 61 cases in each group accorded to the different treatment methods, the control group was received naloxone treatment, the observation group was given Shuxuetong Injection therapy based on the control group treatment, all the cases were given reated 28 d.Results The total effective rate of the observation group and the control group was 98.4% and 86.9% respectively, and the observation group was significantly higher than that of the control group (P<0.05). After treatment, the value of Vmax and PAPs in the two groups were significantly lower than that before treatment (P<0.05), and the value of Vmax and PAPs in the observation group after treatment were significantly lower than that of the control group (P<0.05). The plasma ET-1 content in the observation group and the control group after treatment were significantly lower than that before the treatment (P<0.05), and the observation group were also significantly lower than that of the control group (P<0.05). After treatment, the values of PT, APTT and TT were higher than those before treatment (P<0.05), and the values of PT, APTT and TT in the observation group were also higher than those of the control group after the treatment (P<0.05).Conclusion The Shuxuetong injection can inhibit the expression of plasma ET-1 and improve the pulmonary artery pressure in patients with acute exacerbation of chronic pulmonary heart disease, and it has anticoagulant effect, which is beneficial to improve the therapeutic effect."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁 > 過刊瀏覽>2018年第41卷第12期 >2018,41(12):2308-2312. DOI:10.7501/j.issn.1674-6376.2018.12.035
上一篇 | 下一篇

疏血通注射液聯(lián)合納洛酮治療慢性肺心病急性加重期的臨床研究

Effect of Shuxuetong Injection on plasma endothelin in acute exacerbation of chronic pulmonary heart disease

發(fā)布日期:2018-12-17
您是第位訪問者
藥物評(píng)價(jià)研究 ® 2025 版權(quán)所有
技術(shù)支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號(hào) 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號(hào):(津)-非經(jīng)營性-2015-0031